Abstract: A illuminated table or desk top water display ornament can be used for everyday enjoyment and appropriate for every season and occasion. The water display ornaments embody a multiplicity of water displays, such as waterfalls, springs, waves, tides, cavitating bubbles, and the like, all combined and cycled in one system. The water display ornaments are simple in construction and maintain an aesthetically pleasing presentation to the viewer. Many options are available as a plug-in or slide-in module. This allows the viewer to change modules if desired to obtain different patterns, flows and sounds as desired. The water display ornaments can be efficacious modalities for attenuating an individual's adverse response to daily, weekly, annual or seasonal circadian cycles, such as seasonal affective disorder. Moreover, the water display ornaments offer life prolonging benefits similar to that attributed, by anecdotal evidence, to the ownership of a pet.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: Disclosed is a hair care appliance comprising a body, a fluid flow path extending through the body from a fluid inlet to a fluid outlet and a PCB extending about the fluid flow path. The PCB may be annular. The PCB may be isolated from the fluid flow path. The PCB may comprise a first layer and a second layer. The first layer may extend substantially continuously about the fluid flow path and the second layer may extend partially about the fluid flow path. The second layer may be adjacent the first layer and may be downstream of the first layer. The body may comprise a duct and the fluid flow path extends through the duct. The PCB may extend about the duct. The body may comprise a primary fluid flow path extending about the duct which may be in fluid communication with the PCB.

Abstract: A communication system includes a front-end audio gateway or bridge and a hands-free device. An automatic speech recognition platform accessible to the hands-free device provides or makes available one or more preprocessing schemes and/or acoustic models to the front-end audio gateway or bridge. The preprocessing schemes or acoustic models can be identified by or provided before a connection is established between the front-end audio gateway and the automatic speech recognition platform, when a connection occurs between the front-end audio gateway and the automatic speech recognition platform, and/or during a speech recognition session.

Abstract: An electronic amplifier device amplifies magnetic audio signals emanating from a portable electronic device placed thereon. The electronic amplifier device includes a housing having a designated area for placement of the portable electronic device thereon, an amplifier circuit, and at least one loudspeaker electrically coupled to the amplifier circuit. A wireless audio coupler circuit situated within the electronic amplifier device includes a magnetic signal pick-up coil which is situated in close proximity to the designated area on the housing. The magnetic signal pick-up coil senses magnetic signals emanating from the portable electronic device placed on the designated area of the housing, and the electronic amplifier device amplifies these signals and provides them to the loudspeaker.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: An electronic device and a method for presenting structured data on the electronic device in different operating environments. The method includes selecting, from a plurality of presentation semantics associated with the structured data, a first set of presentation semantics in accordance with an operating environment of the electronic device; processing the structured data in accordance with the first set of presentation semantics; and presenting the structured data processed in accordance with the first set of presentation semantics using the electronic device.

Abstract: The invention provides a boron suboxide composite material comprising boron suboxide and a secondary phase, wherein the secondary phase contains a boride. The boride may be selected from the borides of transition metals of the fourth to eighth groups of the periodic table. Particularly, the boride may be selected from the borides of iron, cobalt, nickel, titanium, tungsten, hafnium, tantalum, zirconium, rhenium, molybdenum or chromium. The boride also may be a platinum group metal boride, preferably palladium boride. The secondary phase also may contain one or more oxides.

Abstract: The invention provides a boron suboxide composite material comprising boron suboxide and a secondary phase, wherein the secondary phase contains a rare earth metal oxide. The rare earth metal oxide may be selected from the oxides of scandium, yttrium, which is preferred, and elements of the lanthanide series, and may be a mixture of rare earth metal oxides. The secondary phase may also include, in addition to the rare earth metal oxide(s), a further oxide or mixture of oxides of an element of the Groups IA, MA, MIA, and IVA of the periodic table. Moreover, the secondary phase may also contain a boride, and particularly a boride selected from the borides of transition metals of the fourth to eighth groups of the periodic table.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: A device, method, and system for switching library managers of a data library while maintaining data library storage devices online. A library manager accepts and executes data transaction commands for access to data residing on the storage devices of the data library. A transition manager module receives a directive to transition library management functions from a first library manager to a second library manager. The transition manager module stops the first library manager from accepting new data transaction commands while maintaining the storage devices online. The first library manager may execute previously accepted data transaction commands. The transition manager module suspends the library management functions of the first library manager and activates the library management functions of the second library manager. The storage devices of the data library may complete data transaction commands throughout the library manager transition.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: The invention relates to compositions of nicotinoyl ribosides and nicotinamide riboside derivatives and their methods of use. In some embodiments, the invention relates to methods of making nicotinoyl ribosides. In some embodiments, the invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinoyl riboside. In further embodiments, the invention relates to methods of using nicotinoyl ribosides and nicotinamide riboside derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival.

Abstract: Compositions comprising a tripeptide having the sequence XC1C2; wherein X is any amino acid such that XC1C2 is capable of binding a metal in a square planar orientation or square pyramidal orientation or both; and wherein C1 and C2 are the same or different; and wherein C1 and C2 individually are chosen from a cysteine and a cysteine-like nonnatural amino acid, as well as metal-XC1C2 complexes and methods for forming such complexes.

Abstract: The invention relates to compositions of nicotinoyl ribosides and nicotinamide riboside derivatives and their methods of use. In some embodiments, the invention relates to methods of making nicotinoyl ribosides. In some embodiments, the invention relates to pharmaceutical compositions and nutritional supplements containing a nicotinoyl riboside. In further embodiments, the invention relates to methods of using nicotinoyl ribosides and nicotinamide riboside derivatives that promote the increase of intracellular levels of nicotinamide adenine dinucleotide (NAD+) in cells and tissues for improving cell and tissue survival.